コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eported to be essential for interaction with S phase kinase-associated protein 1 (SKP1) and RNA silen
2 2, signals its recruitment to the SCF(SKP2) (S-phase kinase associated protein 1 (SKP1)-cullin-SKP2)
3 lls, the cyclin A/CDK2 complex that contains S-phase kinase associated proteins 1 and 2 (SKP1 and SKP
5 and TgPhyA) catalyze prolyl-hydroxylation of S-phase kinase-associated protein 1 (Skp1), a reaction e
6 clear F-box protein that interacts with host S-phase kinase-associated protein 1 (SKP1), suggesting t
7 rt a moonlighting function of two paralogous S-phase kinase-associated protein 1 (Skp1)-related prote
8 d the identified interactions of Fbxl22 with S-phase kinase-associated protein 1 and Cullin1, 2 criti
9 ding experiments indicate that neither SKP1 (S-phase kinase-associated protein 1) nor CCNB1 binding w
10 7 protein by degrading the components of the S-phase kinase-associated protein 1-CUL1-F-box ubiquitin
11 (an F-box protein) and the associated Skp1 (S-phase kinase-associated protein-1)-Cullin1 complex, le
13 essing the transcriptional activation of the S phase kinase-associated protein 2 (Skp2), an F-box pro
14 ation of Notch1 induces transcription of the S phase kinase-associated protein 2 (SKP2), the F-box su
15 we demonstrate that the F-box protein SKP2 (S phase kinase-associated protein 2), the substrate-spec
16 thway to breakdown of p27Kip1 is mediated by S phase kinase-associated protein 2; however, our eviden
18 ), damaged DNA-binding protein 1 (DDB1), and S-phase kinase-associated protein 2 (SKP2) as components
20 s in part by opposing the down-regulation of S-phase kinase-associated protein 2 (SKP2) by the more w
21 derwent K63-linked polyubiquitination by SCF S-phase kinase-associated protein 2 (SKP2) E3 ubiquitin
23 he oncogenic role of the E3 ubiquitin ligase S-phase kinase-associated protein 2 (Skp2) in many types
24 The combo mutant increased expression of S-phase kinase-associated protein 2 (SKP2) in PHHs and H
26 cation pathway in which the E3 F-box protein S-phase kinase-associated protein 2 (SKP2) targets TBET
27 y, B-RAF and cyclin D1 control the levels of S-phase kinase-associated protein 2 (Skp2) that directs
28 e regulators cyclin kinase inhibitor p27 and S-phase kinase-associated protein 2 (Skp2) were assessed
29 kinase inhibitor, and increased the level of S-phase kinase-associated protein 2 (Skp2), a known E3 u
30 s to down-regulated expression of cyclin E1, S-phase kinase-associated protein 2 (SKP2), minichromoso
33 including hepatic induction of cyclin D1 and S-phase kinase-associated protein 2 expression and suppr
34 In the present study, we observed increased S-phase kinase-associated protein 2 mRNA expression in I
38 the expression of the ubiquitin ligase SKP2 (S-phase kinase-associated protein 2), which targets p27
39 KC1 Inhibition of the ubiquitin ligase SKP2 (S-phase kinase-associated protein 2), which targets the
41 uced cellular senescence via inactivation of S-phase kinase-associated protein 2, an important altern
44 Jag-1/Notch2 signaling robustly decreased S-phase kinase-associated protein, an F-box protein that
46 n of p27 associated with decreased levels of S-phase kinase-associated protein (Skp)-2, a ubiquitin l